Shanghai MicroPort MedBot at 2-mth peak as DFVision gets safety recognition

Shanghai MicroPort MedBot (Group)

30/06/2023 05:11

** Shares of Chinese surgical instruments developer Shanghai
MicroPort MedBot Group Co Ltd  2252.HK  jump as much as 17.4% to
HK$24.60, their highest since April 25
    ** Stock extends gains for the second session
    ** Stock on course for the biggest one-day pct rise since
October 14, if gains hold
    ** Stock is the biggest pct gainer in Hang Seng Composite
Index  .HSCI  and seventh biggest pct gainer on the Hong Kong
bourse
    ** Shanghai-based company says its self-developed DFVision
3D Electronic Laparoscope has been approved by the British
Standards Institution (BSI) and obtained the EU CE mark, a
recognition of the product's safety and foundation for its
clinical application and international market entry 
    ** DFVision can be used in intraoperative exploration and
imaging for laparoscopic surgery to make observation, diagnosis,
treatment of abdominal and thoracic organs, and is suitable for
general surgery as well as urology, thoracic, gynecology and
other multi-department surgery
    ** The Hang Seng Composite Index  .HSCI  gains 0.1% and the
healthcare index  .HSCIH  gains 0.5%
    ** The Hang Seng Commerce & Industry Index  .HSNC  eases
0.2% and the Hang Seng Index  .HSI  slips 0.1%
    ** As of last close, the stock has dropped 34.1% this year

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))